These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 1551082)

  • 41. Chromosomal characteristics of Ph-positive chronic myelogenous leukemia in transformation. A study of 23 Chinese patients in Taiwan.
    Tien HF; Chuang SM; Wang CH; Lee FY; Chien SH; Chen YC; Shen MC; Liu CH
    Cancer Genet Cytogenet; 1989 May; 39(1):89-97. PubMed ID: 2731152
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The onset of CML in blastic crisis: molecular features.
    Gregorini A; Filippetti A; Luchetti F; Walker A; Lillington DM; Papa S; Valentini M
    J Biol Regul Homeost Agents; 1997; 11(3):111-4. PubMed ID: 9498160
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Blast crisis of chronic myelocytic leukemia that was difficult to differentiate from Ph+ acute lymphoblastic leukemia].
    Kaneko J; Uchiyama T; Oyake T; Enomoto S; Ono Y; Sugawara T; Numaoka H; Shimosegawa K; Itoh S; Murai K; Ishida Y; Kuriya S
    Rinsho Ketsueki; 1999 Nov; 40(11):1174-80. PubMed ID: 10624128
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The addition of daunorubicin to imatinib mesylate in combination with cytarabine improves the response rate and the survival of patients with myeloid blast crisis chronic myelogenous leukemia (AFR01 study).
    Deau B; Nicolini FE; Guilhot J; Huguet F; Guerci A; Legros L; Pautas C; Berthou C; Guyotat D; Cony-Makhoul P; Gardembas M; Michallet M; Hayette S; Cayuela JM; Weiss IR; Réa D; Castaigne S; Mahon FX; Guilhot F; Rousselot P
    Leuk Res; 2011 Jun; 35(6):777-82. PubMed ID: 21145590
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The usefulness of the bcr/abl rearrangement in the diagnosis and evolution of chronic myeloid leukemia].
    González FA; Villegas A; Ferro MT; San Román C; Sáez I; López M; del Potro E; Alvarez A; Martínez R; Díaz Madiavilla J
    Med Clin (Barc); 1993 Oct; 101(14):521-4. PubMed ID: 8231395
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Chronic myelogenous leukemia in chronic phase transforming into acute leukemia under treatment with dasatinib 4 months after diagnosis.
    Nakamura Y; Tokita K; Nagasawa F; Takahashi W; Nakamura Y; Sasaki K; Ichikawa M; Mitani K
    Int J Hematol; 2016 Mar; 103(3):348-53. PubMed ID: 26662559
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Extramedullary blast crisis derived from 2 different clones in the central nervous system and neck during complete cytogenetic remission of chronic myelogenous leukemia treated with imatinib mesylate.
    Matsuda M; Morita Y; Shimada T; Miyatake J; Hirase C; Tanaka M; Tatsumi Y; Maeda Y; Kanamaru A
    Int J Hematol; 2005 May; 81(4):307-9. PubMed ID: 15914360
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Lymphoid blast crisis during interferon-alpha therapy in a patient with chronic myelogenous leukemia in myeloid blast crisis.
    Goto H; Tsurumi H; Hara T; Moriwaki H
    Int J Hematol; 2000 Dec; 72(4):474-6. PubMed ID: 11197215
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Analysis of isodicentric Ph chromosomes in chronic myeloid leukemia blast crisis].
    Li Q; Lin X; Lin Y; Yao R; Huang W; Mei H; Gong J; Chen H; Teng N
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2017 Feb; 34(1):85-88. PubMed ID: 28186602
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Cytogenetic and clinical features of Philadelphia chromosome positive leukemias].
    Becher R; Kloke O
    Verh Dtsch Ges Pathol; 1990; 74():36-42. PubMed ID: 1708614
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cytogenetic and immunogenotypic alterations of blast crisis cells in chronic myelogenous leukemia independently linked to immunophenotypic expression.
    Murakami T; Ohyashiki K; Ohyashiki JH; Kawakubo K; Tauchi T; Nakazawa S; Kimura N; Toyama K
    Cancer Genet Cytogenet; 1994 Jan; 72(1):48-54. PubMed ID: 8111739
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia or Chronic Myeloid Leukemia in Lymphoid Blast Crisis.
    Kolenova A; Maloney KW; Hunger SP
    J Pediatr Hematol Oncol; 2016 Aug; 38(6):e193-5. PubMed ID: 27164534
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Complete cytogenetic and molecular remission in a case of lymphoid blast crisis in chronic myeloid leukemia with intensive chemotherapy and interferon alpha.
    Fabbiano F; Santoro A; Di Trapani F; Marino MA; Pampinella M; Caronia F
    Eur J Haematol; 1993 Aug; 51(2):122-3. PubMed ID: 8370420
    [No Abstract]   [Full Text] [Related]  

  • 54. Lymph node blast crisis of chronic myelogenous leukemia. One case report.
    Hwang SM; Chen TP; Liu HW; Lin SF; Chang CS; Liu TC; Yen JH; Tsai WJ
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1990 Jun; 6(6):302-8. PubMed ID: 2374182
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Ph1 positive myeloblastic crisis followed by Ph1 negative, bcr rearrangement positive T lymphoid crisis in a CML case].
    Matsushita K; Arima N; Fukumori J; Daitoku Y; Hidaka S; Ohtsubo H; Tanaka H
    Rinsho Ketsueki; 1993 Mar; 34(3):348-54. PubMed ID: 8479087
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Minimal residual disease in patients with chronic myelogenous leukemia undergoing long-term treatment with recombinant interferon alpha-2b alone or in combination with interferon gamma.
    Opalka B; Wandl UB; Becher R; Kloke O; Nagel-Hiemke M; Moritz T; Beer U; Seeber S; Niederle N
    Blood; 1991 Nov; 78(9):2188-93. PubMed ID: 1932740
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Relationship of bcr breakpoint to chronic phase duration, survival, and blast crisis lineage in chronic myelogenous leukemia patients presenting in early chronic phase.
    Morris SW; Daniel L; Ahmed CM; Elias A; Lebowitz P
    Blood; 1990 May; 75(10):2035-41. PubMed ID: 2337672
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Overall survival with ponatinib versus allogeneic stem cell transplantation in Philadelphia chromosome-positive leukemias with the T315I mutation.
    Nicolini FE; Basak GW; Kim DW; Olavarria E; Pinilla-Ibarz J; Apperley JF; Hughes T; Niederwieser D; Mauro MJ; Chuah C; Hochhaus A; Martinelli G; DerSarkissian M; Duh MS; McGarry LJ; Kantarjian HM; Cortes JE
    Cancer; 2017 Aug; 123(15):2875-2880. PubMed ID: 28387926
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Interferon in the eradication of the Philadelphia chromosome in chronic myeloid leukemia].
    Arana-Trejo RM; Ovilla-Martínez R; Gómez-Morales E; Meillon-García L; Cervantes-Peredo A; González-Llaven J; Pizzuto-Chávez J; Kofman-Alfaro S
    Rev Invest Clin; 1997; 49(3):209-14. PubMed ID: 9380976
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Results of therapy with interferon alpha and cyclic combination chemotherapy in patients with philadelphia chromosome positive chronic myelogenous leukemia in early chronic phase.
    Giles FJ; Kantarjian H; O'Brien S; Rios MB; Cortes J; Beran M; Koller C; Keating M; Talpaz M
    Leuk Lymphoma; 2001 Apr; 41(3-4):309-19. PubMed ID: 11378543
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.